DMSO Cream for Knee Osteoarthritis: Not Recommended to Postpone Knee Replacement
DMSO cream is not mentioned in any major clinical practice guidelines for knee osteoarthritis management and should not be relied upon to postpone knee replacement. The FDA has only approved DMSO for interstitial cystitis (bladder instillation), not for topical use on joints 1.
What the Guidelines Actually Recommend
The most recent authoritative guidelines from AAOS (2022) and ESCEO/OARSI (2019-2021) make no mention of DMSO as a treatment option for knee osteoarthritis 2, 3. This absence is telling—if DMSO were effective for postponing knee replacement, it would appear in these comprehensive evidence-based guidelines.
Evidence-Based Treatments That Actually Work
Instead, the guidelines recommend this algorithmic approach for postponing knee replacement:
First-line interventions:
- Weight loss (if overweight/obese) - demonstrated benefits for pain and function 3
- Physical therapy and exercise
- Patient education
Second-line pharmacological options:
- Oral NSAIDs - consistently demonstrate improved pain and function 3
- Intra-articular corticosteroid injections - supported by 19 high-quality studies, though benefits last only ~3 months 3
- Acetaminophen - effective but carries FDA black box warning 3
Controversial options with limited support:
- Platelet-rich plasma - some evidence but inconsistent, worse in severe OA 3
- Hyaluronic acid - NOT routinely recommended due to inconsistent evidence (number needed to treat = 17) 3
The Limited Research on DMSO for Knee OA
While DMSO is absent from guidelines, there is some older research:
The only relevant study is from 1995, showing DMSO gel 25% had modest analgesic effects compared to placebo over 3 weeks in 112 patients 4. However, this study:
- Is nearly 30 years old
- Only lasted 3 weeks (far too short to assess ability to postpone surgery)
- Showed no data on preventing or delaying knee replacement
- Has never been replicated or validated
More recent studies (2009-2011) examined topical diclofenac in DMSO vehicle for knee OA 5, 6. Critically, these studies showed that DMSO vehicle alone was no more effective than placebo 5. The benefit came from the diclofenac (an NSAID), not the DMSO. This directly contradicts any claim that DMSO itself treats knee OA.
Critical Safety Concerns
The FDA label for DMSO warns of 1:
- Hypersensitivity reactions
- Potential eye changes with prolonged use (requiring slit lamp examinations)
- Garlic-like taste and odor lasting up to 72 hours
- Drug interactions affecting other medications
Most importantly: DMSO is FDA-approved only for bladder instillation in interstitial cystitis, not for topical joint application 1.
Clinical Bottom Line
Do not recommend DMSO cream to postpone knee replacement. There is:
- Zero guideline support
- No evidence it delays surgery
- Only one outdated, short-term study showing modest pain relief
- Clear evidence that DMSO vehicle alone is no better than placebo 5
What to Do Instead
For patients hoping to avoid or delay knee replacement, follow the evidence-based algorithm:
- Optimize conservative measures: Weight loss, physical therapy, activity modification
- Trial oral NSAIDs (if no contraindications) - strongest evidence 3
- Consider intra-articular corticosteroid injections for temporary relief (3 months) 3
- Avoid unproven treatments like DMSO cream, which waste patient money and delay effective interventions
The harsh reality: Up to 20% of patients remain dissatisfied after knee replacement 2, but this doesn't validate using unproven treatments. When conservative measures fail and quality of life is significantly impaired, knee replacement remains the definitive treatment for end-stage knee OA 2, 3.